NIH-funded research R01 grant

Defining neutrophil biology in pediatric Long COVID

Official title: Defining neutrophil pathobiology in pediatric Long COVID

Funded at Ut Southwestern Medical Center · NIH-11473912 · Data updated 2026-11-12

This project looks at why some kids develop Long COVID by studying neutrophils to help find new ways to diagnose and treat the condition.

More Long COVID research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startMay 1, 2024
Project endFebruary 28, 2029
Funding year2026
Award (this year)$752,976
NIH project number7R01HL173059-03
Project IDNIH-11473912 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are children with a history of SARS-CoV-2 infection who exhibit Long COVID symptoms, compared with age-matched healthy controls.

Less likely to help

Children without Long COVID or without a history of SARS-CoV-2 infection are unlikely to benefit from this neutrophil-focused study.

What this research studies

Children who had COVID-19 and continue to have symptoms are being studied to understand the role of neutrophils in Long COVID. The study will compare neutrophil activation and function in affected kids versus healthy controls using single-cell RNA sequencing and microfluidic tests. Researchers also plan to collaborate with an existing trial of larazotide to see if reducing spikes in the blood can reverse neutrophil changes. The goal is to uncover measurable markers and therapeutic targets to improve care for pediatric patients with Long COVID. This work could lead to earlier diagnosis and better treatment options for children affected by this condition.

Why it matters

Potential benefit: If successful, this research could enable earlier diagnosis and new treatments for children with Long COVID by targeting neutrophil-driven inflammation.

How similar studies have gone: Preliminary data in adult Long COVID suggest neutrophil abnormalities may persist and relate to symptoms, supporting translation to pediatric populations.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Yonker, Lael — Ut Southwestern Medical Center
  • Study coordinator: Yonker, Lael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.